Algo version: 0.98b
RYTM is listed at the NASDAQ Exchange
RYTM [RYTM]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is RYTM stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Rhythm Pharmaceuticals 10 years ago, but if you had invested on Thursday 5th of October 2017 when the price was $30.00, you would have made a profit of $19.26 per share or 64.20%

Yes, the average daily trading liquidity for Rhythm Pharmaceuticals is $21.06 million. You should therefore be able to get in and out of your positions relatively fast.

Rhythm Pharmaceuticals has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Rhythm Pharmaceuticals to be high [0.85 out of 1]